Skip to content

Open for responses

CHEGAR Mozambique

STATE, DEPARTMENT OF

Notice type
Justification
Solicitation #
72065621C00001
NAICS
488999
PSC
V999
Posted
November 5, 2026
Response due
—

What this opportunity is

The Department of State is seeking a non-competitive increase in funding and scope for the CHEGAR project, which focuses on the transportation and distribution of healthcare commodities in Mozambique, particularly for HIV, malaria, maternal and child health, and tuberculosis programs. This opportunity is relevant for small businesses with capabilities in logistics and healthcare supply chain management, as it involves a transition of services from the Global Health Supply Chain project to CHEGAR. As this is a justification notice, interested parties should track the developments rather than prepare to bid immediately.

Analysis by Mindy, grounded in the SAM.gov notice.

Description

SBU - CONTRACTING AND ACQUISITIONS -- 1 of 15 -- Page 2 of 15 The Laboratory Sample Transportation (LST) and distribution from c entral to provincial/intermediate level is currently implemented by the project Global Health Supply Chain – Procurement and Supply Management (GHSC-PSM) and is expected to end on March 31, 2027. These activities are proposed to start on/around November 1,2026 to avoid disruption of services which would allow for 2-4 months to ensure a smooth transition from GHSC-PSM to CHEGAR. This is a request to approve a non-competitive increase in contract funding and scope of work for contract number 72065621C00001 with Africa Global Logistics (AGL) , in support of the Commodities for Health Guaranteed Access and Reliability (CHEGAR ) and the President’s Emergency Plan for AIDS (PEPFAR) programs to transition the LST and central distribution activities from (GHSC-PSM) The CHEGAR project plays a pivotal role in transportation and distribution of healthcare commodities to the last mile in Mozambique t hrough strategic engagement with the private sector. Operating across eleven provinces and around 1900 delivery sites, the program improves the availability of prevention, testing, and treatment commodities, ensuring the accessibility of healthcare commodities nationwide, particularly in underserved and hard-to-reach areas. These efforts are critical to achieving lasting health outcomes and supporting national HIV, Malaria, MCHN and TB programs. CHEGAR is implemented by AGL which has proven experience in the distribution and sample transport activities. A modification to increase the funding and scope of work to the CHEGAR contract will solidify the transport activities ov ersight from USAID to the Department of State (DOS), which has already been effectively implemented. This adjustment will ensure the program’s continued effectiveness and sustainability, preserving a mature, robust, and functional initiative that aligns with the U.S. Government’s commitments to PEPFAR and the national HIV and TB response. The increase will maintain essential services such as antiretrovirals (ARVs), malaria treatments, rapid diagnostics tests for HIV and malaria, maternal and child health supplies, surgical materials, laboratory commodities, vaccines, laboratory sample transportation and distribution from central level to the provincial/intermediate level The current contract expires on April 01, 2028. This action is critical to prevent a lapse in services that would pose an immediate risk to public health and human life in Mozambique. SECTION 3: DESCRIPTION OF SUPPLIES/SERVICES REQUIRED TO MEET THE AGENCY’S NEEDS SBU - CONTRACTING AND ACQUISITIONS -- 2 of 15 -- Page 3 of 15 Mozambique carries a high burden of HIV and tuberculosis (TB), with a national HIV prevalence of 12.5% and one of the highest rates of multidrug-resistant TB globally. Timely, accurate, and accessible diagnostic services are critical to achieving epidemic control and improving health outcomes for affected populations. In response to these challenges, the Ministry of Health (MISAU), in collaboration with the United States Government (USG)—primarily through PEPFAR—has made significant investments to expand and strengthen the country's diagnostic infrastructure. The USG currently allocates nearly $400 million annually to Mozambique’s health sector, with approximately $50 million dedicated specifically to HIV and TB diagnostic efforts. These investments have yielded notable gains, including increased access to viral load (VL) and early infant diagnosis (EID) testing, and the broader deployment of GeneXpert platforms across the country. However, persistent challenges continue to hinder the diagnostic network’s effectiveness. These include inefficiencies in sample transport, shortages of skilled personnel, inadequate cold chain systems, and prolonged turnaround times for test results. Rural and hard- to-reach areas remain especially underserved. The LST was being implemented by AGL through a USAID contract, under the project name AMOSTRA (Adapting and Modifying Optimized Sample Transport Routes for Achieving Impact), which was terminated during the Stop Work Order in March of 2025, and transitioned under the management of GHSC-PSM with the current name Laboratory Sample Transportation (LST). During this process AGL was shifted to a subcontractor but is still providing overall management of the activity. Transitioning this activity back to AGL would therefore create minimal disruption. This activity will be operated under the supervision of the GRM and will aim at increasing access to diagnostic testing while improving the timeliness of diagnostic test results by ensuring shortened turnaround times between specimen collection, drop-offs, and return of results. The activity will also assure the quality of diagnostic testing through proper handling of specimens and through support of a national platform for specimen transport reporting, monitoring and coordination that leads to continuous quality improvement of specimen transport. SBU - CONTRACTING AND ACQUISITIONS -- 3 of 15 -- Page 4 of 15 In addition to the LST, GHSC-PSM also implements the distribution from central to provincial/intermediate, which involves distribution of commodities funded by the USG (ARVs, malaria treatment, laboratory consumables and Rapid Diagnostic Tests, as well as TB commodities when space is available) from central to provincial/intermediate level. CHEGAR is well positioned to take on these distribution activities, given their current role in the last mile distribution (provincial/intermediate to health facility level) and overall expertise in transportation services The Commodities for Health Ensuring Guaranteed Access and Reliability (CHEGAR) activity is designed to establish a reliable and efficient transportation system for medical commodities in Mozambique. Through strategic engagement with the private sector, CHEGAR p…

Source: SAM.gov, as posted. Verify the current solicitation before responding.

Pursue this opportunity with Mindy

See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.

View the original notice on SAM.gov ↗

Open opportunities in NAICS 488999